Concepedia

Author

Kenichi Hiramatsu

Kyoto UniversityORCID

Also Known As

Hiramatsu, Kenichi, K HIRAMATSU, K Hiramatsu, K. HIRAMATSU, K. Hiramatsu, Kazuma Hiramatsu, Kenichi Hiramatsu

63

Publications

2.2K

Citations

20

H-Index

62

Concepts

All Affiliations

Kyoto UniversityTokyo Medical and Dental UniversitySt. Marianna University School of MedicineUniversity of LouisvilleAugusta University
KH

About

Kenichi Hiramatsu is an author at Kyoto University specializing in pharmacology, medicine, and engineering.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

1.2K

2

Engineering

8

8

427

3

Natural Sciences

7

7

504

4

Health Sciences

1

1

24

5

Public Health

1

1

10

Kenichi Hiramatsu

×

24

Publications

2.1K

Citations

19

H-Index

YearCitations

CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer

Tomohiko Mori, Ryuichiro Doi, Masayuki Koizumi,

Molecular Cancer Therapeutics

2004

407

T140 analogs as CXCR4 antagonists identified as anti‐metastatic agents in the treatment of breast cancer

Hirokazu Tamamura, Akira Hori, Naoyuki Kanzaki,

FEBS Letters

2003

281

Asymmetric Fluorination of Enamides: Access to α-Fluoroimines Using an Anionic Chiral Phase-Transfer Catalyst

Robert J. Phipps, Kenichi Hiramatsu, F. Dean Toste

Journal of the American Chemical Society

2012

208

Molecular‐Size Reduction of a Potent CXCR4‐Chemokine Antagonist Using Orthogonal Combination of Conformation‐ and Sequence‐Based Libraries

Nobutaka Fujii, Shinya Oishi, Kenichi Hiramatsu,

Angewandte Chemie International Edition

2003

202

Identification of a CXCR4 antagonist, a T140 analog, as an anti‐rheumatoid arthritis agent

Hirokazu Tamamura, Miho Fujisawa, Kenichi Hiramatsu,

FEBS Letters

2004

137

Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140

Hirokazu Tamamura, Akane Omagari, Kenichi Hiramatsu,

Bioorganic & Medicinal Chemistry Letters

2001

109

Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonistsElectronic supplementary information (ESI) available: Fig. S1: behaviors of TF14013, TF14016 and TF14013-Me in mouse serum; Fig. S2: behaviors of TF14002 (a), TF14005 (b), TF14006 (c), TF14013 (d), TF14016 (e) and TF14013 analogs (f) in rat liver homogenate; Table S1: characterization data of novel synthetic peptides; and HPLC charts for synthetic compounds of 4F-benzoyl-TE14011 (TF14013), 4F-benzoyl-TN14003 (TF14016), nicotinoyl-TE14011 (TF14031) and 4F-benzoyl-TE14011-Me (TF14013-Me), and for a degraded sample of 4F-benzoyl-TE14011 (TF14013) in rat liver homogenate and its co-injection with an authentic compound des-[Arg14-NH2]-4F-benzoyl-TE14011. See http://www.rsc.org/suppdata/ob/b3/b306613b/

Hirokazu Tamamura, Kenichi Hiramatsu, Makiko Mizumoto,

Organic & Biomolecular Chemistry

2003

95

A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma

Mitsuko Takenaga, Hirokazu Tamamura, Kenichi Hiramatsu,

Biochemical and Biophysical Research Communications

2004

95

Stereoselective Synthesis of [<scp>l</scp>-Arg-<scp>l</scp>/<scp>d</scp>-3-(2-naphthyl)alanine]-Type (<i>E</i>)-Alkene Dipeptide Isosteres and Its Application to the Synthesis and Biological Evaluation of Pseudopeptide Analogues of the CXCR4 Antagonist FC131

Hirokazu Tamamura, Kenichi Hiramatsu, Satoshi Ueda,

Journal of Medicinal Chemistry

2004

92

The development of Weinstein′s noise sensitivity scale

Hiroki Kishikawa, Toshiaki Matsui, Iwao Uchiyama,

Noise and Health

2006

63

Page 1